ENTITY
Shanghai Medicilon

Shanghai Medicilon (688202 CH)

56
Analysis
Health Care • China
Shanghai Medicilon Inc. develops pharmaceutical products. The Company produces acquired immune deficiency syndrome drugs, anticancer drug sensitizers, genetic engineering vaccines, biomedical intermediates, and other products. Shanghai Medicilon also provides biological analysis, drug safety evaluation, and other services.
more
Exchange Announcement • 17 Mar 2021 17:09

Medicilon: Reminder announcement on changes in shareholders' equity (美迪西:关于股东权益变动的提示性公告)

Exchange Announcement • 08 Jan 2021 16:37

Medicilon'S 2020 Annual Results Forecast Increase Announcement (美迪西2020年年度业绩预增公告)

Exchange Announcement • 18 Dec 2020 16:26

Medicilon'S Announcement On The Release Of Part Of The Pledge Of Shareholders Holding 5% Or More (美迪西关于持股5%以上股东部分股份解除质押的公告)

Exchange Announcement • 10 Dec 2020 18:08

Announcement On The Pledge Of Partial Shares Of Shareholders Holding More Than 5% (关于持股5%以上股东部分股份质押的公告)

No more filings
x